Keywords
Last Name

Megan Healey, PhD, MPH

TitleClinical Assistant Professor
InstitutionBoston University School of Public Health
DepartmentEpidemiology
Address715 Albany St Talbot Building
Boston MA
 Research Expertise & Professional Interests
Megan Healey, PhD, MPH is a molecular epidemiologist with expertise in epigenetics and breast cancer. Dr. Healey uses population-based studies to investigate molecular and behavioral determinants of cancer subtypes and prognosis. Trained as a bench scientist, Dr. Healey completed research fellowships in cancer epigenetics and cancer epidemiology. She transitioned from biomedical science to public health in hopes of leveraging her interdisciplinary background to improve the health of populations. Part of that mission is to help train our future leaders in public health. Dr. Healey is invested in bringing innovative, integrated and practical approaches to learning in the classroom, particularly in large courses. Currently, Dr. Healey teaches Introduction to Epidemiology and Intermediate Epidemiology, and enjoys guest lecturing in Principles of Cancer Epidemiology. In 2015, she received a BUSPH Excellence in Teaching Award. Dr. Healey also serves as co-director of the new MPH Certificate in Epidemiology and Biostatistics.

 Publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Healey MA, Hu R, Beck AH, Collins LC, Schnitt SJ, Tamimi RM, Hazra A. Association of H3K9me3 and H3K27me3 repressive histone marks with breast cancer subtypes in the Nurses' Health Study. Breast Cancer Res Treat. 2014 Oct; 147(3):639-51. PMID: 25224916.
    View in: PubMed
  2. Hossain MZ, Healey MA, Lee C, Poh W, Yerram SR, Patel K, Azad NS, Herman JG, Kern SE. DNA-intercalators causing rapid re-expression of methylated and silenced genes in cancer cells. Oncotarget. 2013 Feb; 4(2):298-309. PMID: 23593653.
    View in: PubMed
  3. Xu L, Wang SS, Healey MA, Faupel-Badger JM, Wilken JA, Battaglia T, Szabo E, Mao JT, Bergan RC. The Ninth Annual American Association of cancer research international conference on frontiers in cancer prevention research. Cancer Prev Res (Phila). 2011 Apr; 4(4):616-21. PMID: 21464034.
    View in: PubMed
  4. Healey MA, Deaton SL, Alder JK, Winnepenninckx V, Casero RA, Herman JG. Id1 overexpression is independent of repression and epigenetic silencing of tumor suppressor genes in melanoma. Epigenetics. 2010 Jul 1; 5(5):410-21. PMID: 20484992.
    View in: PubMed
  5. Cummings SD, Ryu B, Samuels MA, Yu X, Meeker AK, Healey MA, Alani RM. Id1 delays senescence of primary human melanocytes. Mol Carcinog. 2008 Sep; 47(9):653-9. PMID: 18240291.
    View in: PubMed
  6. Ryu B, Kim DS, DeLuca AM, Healey MA, Dunlap S, Fackler MJ, Herman J, Alani RM. Id1 expression is transcriptionally regulated in radial growth phase melanomas. Int J Cancer. 2007 Oct 15; 121(8):1705-9. PMID: 17565736.
    View in: PubMed
Megan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
BU Co-Authors
_
Similar BU People
_
Same Department